Blood-Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs

By Li Di , Edward H. Kerns

Focused on central nervous system (CNS) drug discovery efforts, Blood-Brain Barrier in Drug Discovery educates drug researchers about the blood-brain barrier (BBB) so they can affect important improvements in one of the most significant – and most challenging – areas of drug discovery.

• Written by world experts to provide practical solutions to increase brain penetration or minimize CNS side-effects
• Reviews state-of-the-art in silico, in vitro, and in vivo tools to assess brain penetration and advanced CNS drug delivery strategies
• Covers BBB physiology, medicinal chemistry design principles, free drug hypothesis for the BBB, and transport mechanisms including passive diffusion, uptake/efflux transporters, and receptor-mediated processes
• Highlights the advances in modelling BBB pharmacokinetics and dynamics relationships (PK/PD) and physiologically-based pharmacokinetics (PBPK)
• Discusses case studies of successful CNS and non-CNS drugs, lessons learned and paths to the market

Book details

  • Hardcover: 616 pages
  • Publisher: Wiley; 1 edition (February 9, 2015)
  • Language: English
  • ISBN-10: 1118788354
  • ISBN-13: 978-1118788356

To help us maintain our service, please report any dead links !!!


This content is for gold members only. Log In or Register to see
Tags: , ,

Comments are closed.